
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 6.060 | 6.160 | 0.100 |
Shares | 40.940 | 40.940 | 0.000 |
Bonds | 52.980 | 52.980 | 0.000 |
Convertible | 0.020 | 0.020 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.334 | 15.278 |
Price to Book | 3.469 | 2.127 |
Price to Sales | 1.222 | 1.585 |
Price to Cash Flow | 11.545 | 8.758 |
Dividend Yield | 3.189 | 2.581 |
5 Years Earnings Growth | 5.519 | 12.248 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 46.130 | 11.091 |
Consumer Defensive | 18.830 | 6.681 |
Industrials | 13.070 | 12.563 |
Technology | 8.740 | 17.577 |
Real Estate | 4.970 | 2.754 |
Consumer Cyclical | 4.460 | 12.850 |
Energy | 3.810 | 5.513 |
Number of long holdings: 44
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
iShares 20+ Year Treasury Bond | US4642874329 | 8.44 | 86.77 | +0.32% | |
Novo Nordisk B | DK0062498333 | 8.34 | 450.7 | -5.30% | |
PepsiCo | US7134481081 | 3.90 | 129.09 | +0.02% | |
CVS Health Corp | US1266501006 | 3.80 | 66.81 | +0.36% | |
SAP | DE0007164600 | 3.58 | 249.950 | -0.48% | |
Siemens AG | DE0007236101 | 3.56 | 208.80 | -0.24% | |
Ceska Sporitelna AS 5.737% | XS2676413235 | 3.53 | - | - | |
Pandora A/S 4.5% | XS2596599147 | 3.52 | - | - | |
Electrolux AB 4.125% | XS2540585564 | 3.43 | - | - | |
CEZ AS 2.375% | XS2461786829 | 3.34 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Welzia Ahorro 5 FI | 61.94M | 0.63 | 3.28 | 1.03 | ||
Welzia USA Equity FI | 23.65M | 2.06 | 5.77 | 4.50 | ||
Welzia Crecimiento 15 FI | 19.97M | 0.60 | 5.06 | 3.93 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review